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I M M U N O L O G Y
PGE2 production at sites of tissue injury promotes  
an anti-inflammatory neutrophil phenotype  
and determines the outcome of inflammation 
resolution in vivo
Catherine A. Loynes1, Jou A. Lee1, Anne L. Robertson1,2, Michael JG. Steel1, Felix Ellett1,3, Yi Feng4, 
Bruce D. Levy5, Moira K.B. Whyte4, Stephen A. Renshaw1*
Neutrophils are the first immune cells recruited to a site of injury or infection, where they perform many functions. 
Having completed their role, neutrophils must be removed from the inflammatory site—either by apoptosis and 
efferocytosis or by reverse migration away from the wound—for restoration of normal tissue homeostasis. Disrup-
tion of these tightly controlled physiological processes of neutrophil removal can lead to a range of inflammatory 
diseases. We used an in vivo zebrafish model to understand the role of lipid mediator production in neutrophil 
removal. Following tailfin amputation in the absence of macrophages, neutrophillic inflammation does not resolve,  
due to loss of macrophage-dependent handling of eicosanoid prostaglandin E2 (PGE2) that drives neutrophil removal 
via promotion of reverse migration. Knockdown of endogenous PGE synthase gene reveals PGE2 as essential 
for neutrophil inflammation resolution. Furthermore, PGE2 is able to signal through EP4 receptors during injury, 
causing an increase in Alox12 production and switching toward anti-inflammatory eicosanoid signaling. Our data 
confirm regulation of neutrophil migration by PGE2 and LXA4 (lipoxin A4) in an in vivo model of inflammation 
resolution. This pathway may contain therapeutic targets for driving inflammation resolution in chronic inflam-
matory disease.
INTRODUCTION
Inflammation is a critical process that maintains normal tissue homeo-
stasis following injury or infection, by removing potential pathogens 
and beginning the process of wound repair and healing. Neutrophils 
are the first immune cells recruited to a site of injury or infection, 
where they carry out a number of functions (1). They destroy foreign 
pathogens, control the spread of infection, and thereby minimize 
tissue damage. Neutrophils engulf bacteria and cell debris at the site of 
inflammation through phagocytosis and release antimicrobial mole-
cules by degranulation. Along with the release of reactive oxygen 
species, this activity aids in the destruction of pathogens (2) and 
permits neutrophil penetration into otherwise inaccessible tissues 
(3). Having completed their role, neutrophils must then be removed 
from the inflammatory site for successful inflammation resolution 
to occur. If this tightly controlled physiological process is disrupted, 
then failure of inflammation resolution can lead to inflammatory 
diseases such as chronic obstructive pulmonary disease.
There are several mechanisms by which neutrophils can be re-
moved from sites of inflammation. Caspase-dependent neutrophil 
apoptosis and subsequent efferocytosis by macrophages have been 
shown to contribute to the successful resolution of inflammation 
in mouse (4), human (5), and zebrafish (6). Natural killer cells can 
also induce granulocyte apoptosis as a proresolving mechanism (7). 
Neutrophil apoptosis is tightly coupled to uptake by macrophages 
to prevent tissue damage (8). Macrophages phagocytose pathogens 
and apoptotic cells and contribute to inflammation resolution (9), 
tissue remodeling, and regeneration (9, 10); however, their influence 
on inflammation resolution is incompletely defined.
More recently, it has been demonstrated that neutrophils can also 
undergo reverse migration away from sites of inflammation, which, 
in some circumstances, might contribute to the dissipation of the 
inflammatory burden and hence to inflammation resolution (11, 12). 
In the zebrafish, reverse migration is anti-inflammatory and is sup-
pressed by proinflammatory stimuli such as hypoxia (13). Variations 
on this process have also been seen in mouse models (14, 15) and in 
human neutrophils (16, 17). Understanding the molecular mecha-
nisms that govern neutrophil removal, either via efferocytosis or via 
reverse migration, is essential to developing new therapeutics for in-
flammation resolution.
Macrophages are well known to be key mediators in determining 
the outcome of the inflammatory response (18). Macrophages and 
neutrophils secrete a range of pro- and anti-inflammatory cytokines, 
dependent on the local inflammatory environment. Studies in mam-
malian systems (19, 20) have shown that upon uptake of apoptotic 
cells, macrophages regulate pro- and anti-inflammatory cyto-
kine production (21). When fed with apoptotic neutrophils, lipo-
polysaccharide-stimulated human monocyte-derived macrophages 
down- regulate key proinflammatory cytokines and up-regulate anti- 
inflammatory mediators transforming growth factor–1 (TGF1), 
prostaglandin E2 (PGE2), and platelet activating factor (PAF). Prosta-
glandins, such as PGE2, are not stored in cells, but rather produced 
following arachidonic acid metabolism and therefore can be pro-
duced by almost all cells in the body (22). PGE2 is the most abundant 
prostaglandin in humans (23) generated via the action of cyclooxy-
genase enzymes. While PGE2 is known to have proinflammatory 
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properties under defined conditions (24), it has also been shown to 
have anti-inflammatory functions (25). In zebrafish cancer models, 
inhibition of PGE2 production led to a change in macrophage be-
havior and enhanced proinflammatory activity (26), consistent with 
PGE2 directing macrophages toward an anti-inflammatory pheno-
type (27). In human peripheral blood neutrophils, PGE2 switches 
lipid mediator biosynthesis from predominantly proinflammatory 
leukotriene B4 [LTB4; 5-lipoxygenase (5-LO)–initiated pathway] to 
lipoxin A4 (LXA4), which reduces neutrophil infiltration into exu-
dates (28). These studies support a role for PGE2 in influencing im-
mune cell phenotype and led us to ask whether macrophages might 
be altering local lipid mediator signaling as a mechanism for influ-
encing inflammation resolution in vivo.
Using a zebrafish model of in vivo inflammation resolution, we 
examined the potential role of the lipid mediator PGE2 in driving 
inflammation resolution. We demonstrate that macrophage uptake 
of apoptotic cells is necessary for successful inflammation resolu-
tion; PGE2 is produced and acts via EP4 receptors to drive inflam-
mation resolution by reverse migration.
RESULTS
Macrophage clearance of apoptotic cells is necessary for 
successful resolution of neutrophilic inflammation in vivo
Inflammation requires the presence and activity of both neutrophils 
and macrophages. To test whether neutrophil dynamics were influ-
enced by the presence of macrophages, we ablated macrophages 
using tissue-specific bacterial nitroreductase expression and by treat-
ment with metronidazole as previously described (29, 30). Injury was 
performed on 3 days post fertilization (dpf) macrophage-ablated 
larvae, and neutrophil and macrophage numbers were assessed at 
the time points indicated (Fig. 1A). In control larvae, neutrophil 
numbers peaked between 4 and 6 hours post injury (hpi), with num-
bers returning to basal levels by 24 hpi, demonstrating spontaneous 
resolution of inflammation. Macrophages were recruited to the site 
of injury at a lower rate, with numbers plateauing at 12 hpi and re-
maining high until at least 24 hpi. In metronidazole-treated larvae, 
macrophages were not seen at the wound throughout the inflamma-
tory time course, confirming successful ablation. Neutrophil numbers 
at the wound site were significantly increased at 24 hpi in macrophage- 
depleted larvae compared to control larvae, suggesting failed in-
flammation resolution (Fig. 1, A and B). In contrast to wound-site 
neutrophils, whole-body neutrophil counts were unaltered (Fig. 1C). 
These data demonstrate that macrophages are necessary at the site 
of tissue injury for normal inflammation resolution to occur.
In many models of inflammation, including the zebrafish, apop-
tosis of neutrophils contributes to inflammation resolution (6, 31). 
It might therefore be expected that macrophage depletion would 
leave apoptotic neutrophils at the wound site. To test whether the 
persistence of apoptotic corpses explained the increase in neutrophil 
numbers, we ablated macrophages by treating transgenic zebrafish 
with metronidazole at 7 dpf, injuring the tailfin as before at 8 dpf 
and then fixing at 24 hpi in 4% paraformaldehyde for TUNEL 
(terminal deoxynucleotidyl transferase–mediated deoxyuridine 
triphosphate nick end labeling) staining. Older larvae were used to 
increase cell numbers involved in the inflammatory response and to 
increase our ability to detect apoptotic events. We costained for 
endogenous peroxidase activity of neutrophils using a modification 
of the tyramide signal amplification (TSA) system (6). Double-stained 
cells corresponding to apoptotic neutrophils were then counted in 
macrophage- depleted larvae. Although the number of neutrophils 
was higher in the metronidazole-treated fish, the percentage of 
these neutrophils that were apoptotic was not different in the 
metronidazole- treated group (Fig. 1D), suggesting that persisting 
apoptotic neutrophil corpses did not account for the increase in 
neutrophil numbers in the absence of macrophages. During 
analysis of these images, we did notice a striking and unexpected 
increase in TUNEL-positive, TSA-negative cells in macrophage- 
depleted larvae (Fig. 1E), corresponding to apoptotic cells from 
nonneutrophil lineages. Representative images of stained cells are 
shown in Fig. 1F. This finding demonstrates that macrophages have 
an important role in removing apoptotic cells arising from tissue 
injury and that neutrophil persistence is not due to uncleared 
apoptotic neutrophils. This suggested to us that the majority of 
neutrophils might be removed from the wound by an alternative 
mechanism, such as reverse migration (12).
Inflammation resolution is not exclusively dictated by direct 
macrophage-neutrophil interaction
Neutrophil-macrophage interaction has been observed during the 
inflammatory response (32) and, under some circumstances, this 
has been shown to alter neutrophil migratory behavior in ways that 
could explain the observed failure of inflammation resolution in the 
absence of macrophages. We therefore sought to analyze neutrophil 
migration before and after interaction with macrophages to see 
whether that interaction caused neutrophils to migrate away from 
the wound, thereby dissipating the inflammatory burden. We tracked 
individual transgenically labeled macrophages and neutrophils, 
monitoring their interaction with other inflammatory cells. We tracked 
neutrophils and macrophages during an inflammatory response 
and plotted their x,y coordinates (Fig. 2A). Interaction between red 
(macrophage) and green (neutrophil) tracks was identified, and for 
each interaction, we identified whether contact between a macro-
phage and a neutrophil induced a significant change in behavior of 
the neutrophil. Direct cell contact was defined as when membranes 
of both cell types could be seen to touch. Interaction with a macro-
phage made no significant difference in the neutrophil meandering 
index (Fig. 2B), suggesting that interaction did not lead to a change 
in migratory behavior. Moreover, analysis of vector maps of neutro-
phils before and after interaction with a macrophage showed no clear 
difference between the two vector maps. The vector maps show the 
overall direction a neutrophil takes during the analyzed period 
(Fig. 2C). When analyzed, the percentage of reverse-migrated neutro-
phils that did not interact with a macrophage was 71%, compared to 
65% of neutrophils reverse-migrating following a macrophage inter-
action (Fig. 2D). There was no significant difference in reverse mi-
gration behavior following macrophage interaction (P = 0.78, Fisher’s 
exact test). Direct contact between macrophages and neutrophils is 
therefore not sufficient to completely explain the observed changes 
in neutrophil direction, suggesting that an additional soluble factor 
is involved.
The eicosanoid PGE2 is necessary for timely  
inflammation resolution
Previous studies in vitro have shown that, following uptake of apop-
totic cells, macrophages can alter both their profile of cytokine produc-
tion and their phenotype, from pro- to anti-inflammatory (21). It has 
been reported that levels of TGF1 and PGE2 increase following 
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Fig. 1. Macrophage clearance of apoptotic cells is necessary for successful resolution of neutrophilic inflammation in an in vivo zebrafish model. (A) Neutrophil 
and macrophage counts at the wound in triple transgenic Tg(cfms:Gal4)i186;Tg(UAS:nfsB-mCherry)i149;Tg(mpx:EGFP)i114 larvae in the presence or absence of metronidazole. 
Neutrophil numbers are significantly higher at the wound in the absence of macrophages at 24 hpi, ***P < 0.0001. Statistics: Two-tailed nonpaired t test comparing 
neutrophil counts at 24 hpi with or without macrophage present. All data are n = 18 from three individual experiments plotted as means ± SEM. (B) Representative photo-
micrographs at 24 hpi showing increased neutrophil numbers at the site of injury in metronidazole-treated larvae compared to control. Wound area classed as area to the 
right of the yellow dashed line. Images were taken using ×10 magnification on a TE2000U inverted microscope (Nikon). (C) Total neutrophil numbers are not affected in 
the absence of macrophages. Data are n = 17 individual larvae. (D) Dual fluorescein isothiocyanate (FITC)–TSA and Rhodamine-TUNEL–positive cell counts in 8 dpf larvae 
at 24 hpi in the presence or absence of metronidazole show no significant difference (ns) in the percentage of apoptotic neutrophils. (E) Total apoptotic cell counts 
of TUNEL-positive cells in 8 dpf larvae at 24hpi. Macrophage-depleted larvae have significantly more apoptotic bodies at the wound, P = 0.0021. All data are presented as 
means ± SEM, n = 12, from two individual experiments for (D) and (E). (F) Representative photomicrographs of 8 dpf larvae at 24 hpi treated with either dimethyl sulfoxide 
(DMSO) control or metronidazole and dual-stained with FITC-TSA to label neutrophils and Rhodamine-TUNEL to label apoptotic cells at the wound (white arrow head). 
Images were taken using ×10 magnification on a TE2000U inverted microscope (Nikon).
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phagocytosis of apoptotic cells, whereas levels of cytokines such as 
interleukin-10 and tumor necrosis factor– fail to increase further. 
When PGE2 production was blocked by indomethacin, TGF1 levels 
remained low, suggesting that PGE2 might be an upstream regulator 
of macrophage phenotype following uptake of apoptotic cells (21). 
We therefore sought to establish whether PGE2 could be a potential 
mediator in enhancing inflammation resolution following tail in-
jury in vivo.
Microsomal PGE synthase, Ptges, is necessary for the conversion 
of prostaglandin H2 into PGE2 (33). PGE2 levels can be significantly 
reduced when Ptges expression is inhibited through the use of a 
morpholino antisense oligo (34). We used a previously published 
morpholino to knock down ptges to test the effect of reduced PGE2 
levels on neutrophil behavior during inflammation. Reverse transcrip-
tion polymerase chain reaction (PCR) demonstrated a significant 
reduction in correctly spliced ptges transcript at 4 dpf (fig. S1). 
Neutrophil counts throughout the inflammatory response revealed 
a significant increase in neutrophil recruitment to the wound site. 
At the later time points, during the resolution phase, significantly 
more neutrophils were retained at the site of injury (Fig. 3A). Since 
Fig. 2. Inflammation resolution is not exclusively dictated by direct macrophage-neutrophil interaction. (A) Neutrophil (eight green lines) and macrophage 
(six magenta lines) tracks during an inflammatory response are plotted using their x,y coordinates. Larval caudal fin outline superimposed over tracks to indicate position 
at wound. (B) The meandering index (migration pattern) of neutrophils before and after contact with a macrophage shows no significant difference. Number of cells tracked: 
14. Two-tailed paired t test. (C) Representative vector maps of overall neutrophil direction pre (green) and post macrophage (magenta) interaction. (D) Neutrophils (65%) 
that interacted with a macrophage reverse-migrated, whereas 71% neutrophils without a macrophage interaction also reverse-migrated away from the wound 
site. Chi-squared Fisher’s exact test indicated no significant difference in reverse migration with or without macrophage contact. P = 0.78.
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PGE2 has been shown to be critical in hematopoiesis (35), we looked 
at total neutrophil number in ptges morphants. Knockdown of ptges 
significantly reduced the number of neutrophils in the whole zebrafish 
(Fig. 3B), demonstrating that the increase in neutrophil numbers seen 
during inflammation is not due to an overall increase in neutrophils 
within the zebrafish. These data demonstrate that Ptges activity plays 
an important role in the resolution of inflammation.
Genetic knockdown of ptges by morpholino has indicated that 
PGE2 production is essential for successful inflammation resolution. 
Because of the well-documented nonspecific effects of some morpholinos 
(36), we wanted to confirm our findings using a second approach. 
To address this, we have used CRISPR/Cas9 technology to support 
our findings (37). We designed a guide RNA (gRNA) that targets 
the ATG of ptges. Successful mutation by Cas9 protein deletes an 
MwoI restriction site, allowing the efficiency of the guide to be 
assessed and the larvae to be genotyped (fig. S4) with an uncut mu-
tant band present at 293 base pairs (bp). Using our tailfin injury 
model, we have injected Tg(mpx:EGFP)i114 embryos at the one-cell 
stage with transactivating crRNA (tracrRNA) and Cas9 protein 
alone or in combination with a control gRNA, targeting tyrosinase 
(tyr) or a gRNA targeting ptges. Tyrosinase is the gene required for 
converting tyrosine into the pigment melanin, enabling visual iden-
tification of successful Cas9 knockdown (38). Genetic knockdown 
of ptges using Cas9 protein also leads to persisting neutrophils at 
the wound site compared to tyr-injected larvae (Fig. 3C), pheno-
copying the ptges morphant. Representative images were taken of 
each group to show this (Fig. 3D). These data strongly support 
the essential role of PGE2 for successful neutrophil removal from 
wound sites.
PGE2 is sufficient to drive inflammation resolution
PGE2 has both anti- (39) and proinflammatory effects dependent on 
the timing of its production and concentration (24, 40). To test whether 
PGE2 is sufficient to drive inflammation resolution, we immersed 
3 dpf transgenic zebrafish larvae in a range of PGE2 concentrations 
at 8 hours after tailfin transection, after peak neutrophil recruitment 
had occurred. Wound neutrophil numbers were then assessed at 12 hpi 
to look for accelerated inflammation resolution. Twelve hours post 
injury is a time point where untreated larvae still have relatively 
high neutrophil numbers, and therefore, an enhanced reduction in 
neutrophil numbers would be detectable. Neutrophil numbers were 
significantly decreased in a dose- dependent manner when treated 
with PGE2, with 1 M chosen as the optimal concentration (Fig. 3E). 
Exogenous PGE2 was able to rapidly enhance neutrophil removal from 
the site of injury to return neutrophil numbers to basal levels, thereby 
promoting successful inflammation resolution. As PGE2 reduced 
neutrophil numbers at the site of injury, we tested whether PGE2 
accelerated neutrophil apoptosis at the wound site. Three days post 
fertilization larvae were injured, treated with PGE2, and fixed at 
12 hpi for dual TUNEL (apoptosis) and TSA (neutrophil) staining. 
There was no difference in apoptotic cell numbers in larvae treated 
with PGE2 compared to control (fig. S2A). This suggests that neu-
trophils are removed through a mechanism other than apoptosis.
Since exogenous PGE2 could enhance inflammation resolution 
in our model, we investigated whether PGE2 could rescue the 
persisting neutrophil phenotype observed with macrophage ablation. 
Zebrafish larvae with nitroreductase-expressing macrophages and 
green fluorescent protein (GFP)–expressing neutrophils were treated 
with metronidazole at 2 dpf, injured at 3 dpf, and treated with PGE2 
at 8 hpi. Cell counts were performed at 12 and 24 hpi. PGE2 was 
able to significantly reduce neutrophil numbers at the wound in 
metronidazole- treated larvae at 12 hpi compared to metronidazole- 
only larvae, with means of 4.6 ± 0.4 and 9.6 ± 0.8, respectively 
(fig. S2B). At 24 hpi, neutrophil numbers remained significantly 
reduced (Fig. 3F). These data demonstrate that PGE2 can drive 
inflammation resolution in the absence of macrophages, thus 
correcting the resulting inflammatory phenotype.
Neutrophil migration pattern, but not speed,  
is modulated by PGE2
During inflammation resolution, neutrophils can be removed through 
multiple mechanisms, including neutrophil apoptosis (41) and re-
verse migration (13, 42). Macrophage depletion did not result in a 
detectable difference in apoptotic neutrophil numbers compared to 
control, due to either residual macrophage activity or the infrequency 
of neutrophil apoptosis in the zebrafish model. Nonetheless, PGE2 
can still reduce neutrophil numbers in these larvae, implying that 
neutrophils involved in the inflammatory response are being removed 
from the site of injury through a mechanism other than efferocytosis. 
We therefore investigated whether PGE2 could enhance inflamma-
tion resolution by acceleration of neutrophil reverse migration in 
tail-transected zebrafish larvae. Using well-established photoconver-
sion protocols (43, 44) in transgenic zebrafish expressing the photo-
convertable fluorophore kaede in neutrophils, we labeled neutrophils 
at the wound site at 8 hours after tailfin transection and observed 
the effects of addition of PGE2. Neutrophils at the wound site were 
tracked during the resolution phase of inflammation for 2 hours, 
from 10 to 12 hpi. Red, photoconverted neutrophils could be seen 
migrating away from the site of injury more readily in PGE2-treated 
larvae (Fig. 4, A to C). PGE2 significantly increased the number of 
neutrophils moving away from the wound area (Fig. 4D). This equates 
to there being a 50% difference in the number of reverse-migrated 
neutrophils in the PGE2-treated fish at 140 min after conversion, 
with a significant P value of 0.0015. These data show that PGE2 drives 
inflammation resolution by enhanced reverse migration away from 
the injury site.
We then asked whether this enhanced migration from the wound 
could be due to an increased migration speed of the neutrophils or to 
them leaving the site of injury sooner. Neutrophil migration speed 
away from the site of injury was measured in the same reverse mi-
gration assays described above (Fig. 4E). There was no significant 
difference in migration speed, implying that PGE2 may enhance re-
lease of neutrophils from their patrolling behavior at the wound site. 
The timing of PGE2 release is therefore critical to allow neutrophils 
to perform their role and then drive them away without compro-
mising the inflammatory response.
Signaling through EP4 receptors contributes to 
inflammation resolution
PGE2 can signal through four prostanoid receptors: EP1, EP2, EP3, 
and EP4 (45). The expression and distribution of these receptors vary 
between different tissues and cell types. EP4 is considered a stimu-
latory receptor and is expressed on human macrophages, with studies 
showing that blockage of EP4 signaling inhibits cytokine release by 
macrophages (46). All four EP receptors are present in zebrafish, 
with multiple paralogs of each receptor (47). EP4b is the most abun-
dant in adult zebrafish and is closest to human EP4 phylogenetically 
(48). To test whether PGE2 could be signaling in vivo through EP 
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Fig. 3. In vivo effects of PGE2 on neutrophils during an inflammatory response through genetic manipulation and PGE2 supplementation. (A) Morpholino knock-
down of endogenous ptges shows the necessity of PGE2 during inflammation resolution, with a significant increase in neutrophil numbers at the wound site at 8 and 24 hpi. 
*P < 0.01, two-way analysis of variance (ANOVA) with Bonferonni’s posttest. Data are n = minimum 30 from three experimental repeats. (B) Total neutrophil numbers in 
unstimulated larvae are reduced (P < 0.05, n = 24 larvae) in the absence of ptges, indicating that the increase during an inflammatory response is not due to increased 
neutrophils numbers overall. (C) Recapitulation of morphant phenotype in crispant. Three days post fertilization larvae with CRISPR/Cas9-mediated knockdown of ptges 
display significantly more neutrophils at the wound site at 24 hpi compared to a control-injected guide group targeting tyr. Injured crispants phenocopy ptges morphants. 
**P < 0.01, ****P < 0.0001, one-way ANOVA with Bonferroni posttest. Data are plotted as means ± SEM with a combined minimum of 40 larvae per group from three experi-
mental repeats. (D) Representative images of crispant larvae at 24 hpi. Area to the right of the magenta dashed line indicates the wound site where GFP neutrophils are 
counted. Brightfield images demonstrate successful tyr knockdown as a reduction in pigmentation is visible. (E) Dose-response showing increasing concentrations of 
PGE2 significantly drive neutrophilic inflammation resolution. PGE2 was added at 8 hpi with neutrophil counts performed at 12 hpi. Neutrophil numbers at the site of injury 
are significantly reduced between 0.01 and 1 M. (F) In the absence of macrophages, exogenous PGE2 is able to significantly reduce neutrophil numbers back to basal 
levels at 24hpi. ***P < 0.001, one-way ANOVA with Bonferroni posttest. Minimum of 32 larvae from three repeats. MTZ, metronidazole.
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receptors, we used a previously published antagonist, AH23848, 
to inhibit EP4 receptor signaling (49). As we were assessing endoge-
nous PGE2 signaling during a natural inflammatory response, where 
neutrophil numbers reduce from around 6 hpi, we performed 
24 hpi counts for inhibitor assays to be able to detect neutrophil per-
sistence over normal basal levels. Neutrophil counts at 24 hpi showed 
a significant increase in number when EP4 signaling was blocked, 
suggesting that endogenous PGE2 may act via this receptor. Addi-
tion of PGE2 at standard doses did not lead to significant abrogation 
of this effect (Fig. 5F). These data suggest that PGE2 signals predomi-
nantly through the EP4 receptor, contributing significantly to inflam-
mation resolution. However, it remained unclear how EP4 signaling 
might lead to altered neutrophil behavior.
Up-regulation of lipoxygenase by PGE2 is necessary  
for inflammation resolution
The metabolism of the membrane lipid arachidonic acid is a complex 
pathway, producing not only prostaglandins but also other eicosa-
noids such as proresolving lipoxins and proinflammatory leukotrienes. 
Lipoxygenases (LOXs) are essential for the production of these metabo-
lites, with select isozymes being key for particular pathways. Previous 
studies have shown that arachidonate 12-lipoxygenase (12-LO) or 
15-lipoxygenase (15-LO) activity, in combination with arachidonate 
5-lipoxygenase (5-LO), can produce lipoxins, and 5-LO activity alone 
forms leukotrienes (50). Increasing concentrations of PGE2 inhibit 
5-LO translocation from the cytoplasm to the nucleus, abrogating 
leukotriene synthesis (51) and skewing the balance between pro- and 
Fig. 4. PGE2 drives accelerated reverse migration through EP4 receptor signaling. (A) Representative photomicrographs of control or PGE2-treated 3 dpf 
Tg(mpx:gal4)sh267;Tg(UAS:kaede)i222 larvae following photoconversion. The area to the right of the white dashed vertical line indicates wound site, where cells were 
photoconverted from green to red fluorescence. The yellow box E indicates the area into which the photoconverted cells migrate and corresponds to data in (D). (B) The 
red channel only is shown as a binary image of a control larva at 0 and 2 hours post conversion (hpc). Very little migration away from the wound site occurs between 10 and 
12 hpi. (C) Binary images of the red channel of a PGE2-treated larva at 0 and 2 hpc. At 12 hpi, neutrophils have migrated away from the wound site, when treated with 
PGE2. (D) Plot showing the number of neutrophils moving away from the wound over 10 to 12 hpi, preincubated with or without PGE2 from 8 to 9 hpi. PGE2-treated neutro-
phils migrate away from the site of injury between 10 and 12 hpi more readily. Line of best fit shown is calculated by linear regression. P value shown is for the difference 
between the two slopes. (E) The speed of neutrophils moving away from the site of injury is not significantly different in the presence of exogenous PGE2, indicating that 
neutrophils migrate away sooner rather than at a greater speed in PGE2-treated larvae. (F) Neutrophil counts at 24 hpi show a significant increase in neutrophil number 
when EP4 signaling is blocked using the antagonist AH23848. **P < 0.01, ****P < 0.0001. Addition of PGE2 does not lead to significant abrogation of this effect, implying 
PGE2 signals through the EP4 receptor to promote neutrophil removal. All data are presented as means ± SEM, from n = 18 larvae for (D) and (E) and n = 53 for (F) from 
three experimental repeats. Images were taken using ×10 magnification on a TE2000U inverted microscope (Nikon).
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anti-inflammatory mediators toward increased lipoxin synthesis—a 
process termed “lipid mediator class switching” (28). Zebrafish have 
the three key LOX genes for lipid mediator synthesis: alox12, alox5, 
and alox15b genes (52–54). To assess the contribution of lipoxin 
production during inflammation resolution in the zebrafish, we im-
mersed injured transgenic larvae in PD146176, a specific 15-LO in-
hibitor (55). Again, as we hypothesized that there would be a delay in 
inflammation resolution, we performed 24 hpi counts for inhibitor 
assays to be able to detect neutrophil persistence over normal basal 
levels. We found that inhibiting 15-LO activity during inflammation 
led to a significant increase in neutrophil numbers at 24 hpi com-
pared to control larvae (Fig. 5A), indicating persisting inflammation 
at the wound site. This effect was dose-dependent (Fig. 5B). Addition 
of exogenous PGE2 following 15-LO inhibition was unable to abrogate 
this effect, with neutrophil numbers remaining high at the wound 
site 24 hpi (Fig. 5C), supporting a mechanism of PGE2 acting up-
stream of 15-LO in this pathway.
The oxygenation of arachidonic acid by LOXs can occur at vary-
ing positions along the fatty acid carbon chain (50) and can deter-
mine the functionality of the protein according to which carbon is 
oxygenated and which amino acid residue is present at specific sites. 
In zebrafish, LOX genes are annotated in Ensembl as alox12 and 
alox15b; we predict that zebrafish Alox12 should function predom-
inantly in the role of a 15-LO due to the presence of phenylalanine 
(F) at position 353 and a bulky valine (V) at position 418 [in com-
parison to the rabbit leukocyte 12-LO protein sequence (56) and as-
sociated with predominantly 15-LO activity in mammalian LOXs 
(57); fig. S3]. We therefore assessed alteration of expression of alox12 
(the zebrafish putative 15-LO) by quantitative PCR (qPCR) during 
injury-induced inflammation. There was a significant linear increase 
in 12-LO expression up to 6 hpi (Fig. 5D), demonstrating that in-
flammation caused by injury induces a change in LOX activity. This 
suggests a plausible mechanism for the induction of reverse migration 
through increased lipoxin production during inflammation resolution.
Lipoxin A4 drives inflammation resolution via  
reverse migration
LXA4 is a proresolving product of arachidonic acid metabolism that 
inhibits neutrophil chemotaxis, transmigration, superoxide generation, 
and the production of proinflammatory cytokines (58). Because alox12 
expression was increased during injury-induced inflammation, we 
next determined whether its key product LXA4 plays a role in inflam-
mation in the zebrafish model. First, we added exogenous LXA4 to 
the injured larvae and assessed neutrophil number at 6 hpi. Our data 
demonstrate a protective effect of LXA4 acting to inhibit neutrophil 
chemotaxis, significantly reducing neutrophil recruitment to the 
wound site (Fig. 6A). This provides evidence that exogenous LXA4 is 
able to promote a response in our in vivo model. If PGE2 production 
following injury increases alox12 activity during inflammation reso-
lution, and thereby increases endogenous LXA4 production, we would 
Fig. 5. EP receptor signaling and downstream activation of LOXs by PGE2 lead to lipid mediator class switching and inflammation resolution. (A) Downstream activ-
ity of 15-LO was inhibited using the antagonist PD146176, also causing a significant delay in neutrophil removal from the wound site at 24 hpi. ****P < 0.0001. Data represent 
three replicates with a minimum of 30 fish per replicate. T test was performed. (B) Varying doses of PD146176 increase neutrophil numbers at the wound site at 24 hpi in a 
dose-dependent manner. (C) Exogenous PGE2 is unable to significantly decrease neutrophil numbers in the presence of the 15-LO inhibitor PD146176 at 24 hpi. ***P < 0.001. 
(D) qPCR expression analysis of alox12 following injury shows a significant increase up to the peak of inflammation. Fold change of expression to the reference gene represents 
the means ± SEM of four replicate experiments per time point, with a minimum of 50 larvae per replicate, therefore n = 200 individual larvae. P = 0.04, r 2 = 0.91.
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predict that LXA4 could allow removal of neutrophils already present 
at the wound site due to loss of sensitivity to local wound signals. To 
assess this, we performed reverse migration experiments in the pres-
ence of exogenous LXA4. LXA4 caused neutrophils to move away 
from the wound earlier than in untreated larvae (Fig. 6B), without 
altering neutrophil migration speed (Fig. 6C) or the path that 
the neutrophils take (Fig. 6D). Our data are best explained by 
proposing that production of endogenous LXA4 by Alox12 fol-
lowing injury-induced PGE2 production is the mechanism that 
promotes inflammation resolution in vivo.
DISCUSSION
Restoration of tissue homeostasis following infection or injury re-
quires successful resolution of inflammation. Inflammation resolution 
should not occur before the threat is ablated, nor should inflamma-
tion persist longer than necessary. The process is therefore tightly 
regulated. Neutrophils and macrophages as a population are well 
positioned to assess the threat to the organism and determine the 
duration of the inflammatory response. Once the resolution is de-
cided, neutrophils can either die at inflammatory sites by apoptosis 
and be cleared by macrophages (5) or can be removed from inflam-
matory sites by altered migratory patterns (reverse migration) (42). 
If this tightly controlled inflammatory process is disrupted, failure 
of inflammation resolution can lead to the tissue damage seen in 
chronic inflammatory diseases (59). The molecular mechanisms con-
trolling the decisions on duration of inflammation are complex and 
yet to be fully determined. Existing evidence indicates that lipid me-
diator secretion is likely to be important in signaling inflammation 
resolution (60), but it is unknown which mediators regulate neutro-
phil removal from sites of inflammation in vivo. We have shown, 
for the first time, that the lipid mediator signaling molecule PGE2 is 
essential for determining the outcome of neutrophil inflammation 
in response to tissue injury. Moreover, our data suggest that alterations 
in LOX activity lead to production of LXA4. This lipid mediator class 
switching appears to be the critical mechanistic step by which macro-
phage PGE2 release after uptake of apoptotic cells promotes inflam-
mation resolution in vivo.
Previous in vitro studies have suggested that phagocytosis of 
apoptotic neutrophils by macrophages might contribute toward 
successful inflammation resolution (21, 61). Ingestion of apoptotic 
cells by macrophages promotes an anti-inflammatory environment, 
suppressing pro inflammatory cytokine production and promoting 
LXA4 production (21). While mice lacking macrophages and neu-
trophils show healing without excessive inflammation or scar forma-
tion, in macrophage- only depleted mice, neutrophils populated the 
wound area, with impaired wound morphology and delayed healing 
(62). We have shown that in the absence of macrophages, apoptotic 
bodies accumulate at the wound site, resulting in neutrophil persistence 
and pro longed inflammation. This finding de monstrates the impor-
tance of understanding macrophage-neutrophil interactions during 
inflammation resolution to prevent further damage to healing tissues.
Recent work has shown that reverse 
migration is a contributor to neutro-
phil removal from inflammatory sites 
(13, 15, 42, 63). It has been shown that 
macrophage recruitment and redox- SFK 
(Src family kinase) signaling play key 
roles in neutrophil-mediated inflamma-
tion resolution (32). These studies also 
suggest a direct contact mechanism be-
tween neutrophils and macrophages, 
which may direct neutrophil reverse 
migration; however, in the absence of 
macrophage contact, neutrophils are 
still able to reverse-migrate, suggesting 
that other, unknown factors may be in-
volved. Tracking analysis of macro phage 
and neutrophil contact in our model of 
inflammation demonstrates that direct 
contact is not an essential requirement 
for reverse migration. Furthermore, our 
studies support the importance of a 
soluble factor, the lipid mediator PGE2, 
for successful inflammation resolution. 
Our data suggest that this lipid media-
tor is a key signaling molecule between 
macrophages and neutrophils during 
inflammation, leading to production of 
LXA4, enhancing neutrophil reverse mi-
gration and, hence, speeding inflamma-
tion resolution.
PGE2 is known to be involved in 
many cellular processes, including cell 
proliferation, apoptosis, angiogenesis, 
Fig. 6. LXA4 drives inflammation resolution via reverse migration. (A) Injection of LXA4 into zebrafish larvae 
causes a small but significant reduction in neutrophil numbers at the wound site at 6 hpi. n = 120 larvae. (B) Plot 
showing the number of neutrophils reverse-migrating away from the wound over a time course of 6 to 15 hpi, prein-
jected at 4 hpi with or without LXA4. LXA4-treated neutrophils migrate away from the site of injury sooner than con-
trol neutrophils. Line of best fit shown is calculated by linear regression. P value shown is for the difference between 
the two slopes. n = 21 larvae. (C) The speed of neutrophils moving away from the site of injury was measured and is 
not significantly different in the presence of exogenous LXA4. (D) The path the neutrophils take (meandering index) 
when moving away from the wound was also not significantly different when supplemented with LXA4. All data are 
presented as means ± SEM, from three experimental repeats.
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inflammation, and immune surveillance (64). The production of 
PGE2 from prostaglandin synthases is essential for the development 
of organisms past the gastrulation stage (34) and is crucial for hema-
topoietic stem cell homeostasis (35). However, to our knowledge, 
PGE2 has not been shown to be necessary for resolution of neutro-
philic inflammation. We have shown by genetic and pharmacological 
approaches that the production of PGE2 is essential for inflamma-
tion to resolve and that PGE2 is sufficient to drive neutrophil removal 
from wound sites. PGE2 can promote neutrophil removal from wound 
sites in the absence of macrophages, implying an important connec-
tion between macrophages and the lipid mediator PGE2. This could 
prove to be a useful target for therapeutic intervention in chronic 
inflammatory disease.
PGE2 acts via EP receptors present on a range of cell types, in-
cluding neutrophils, macrophages, and epithelial and endothelial cells. 
Neutrophils predominantly express EP2 and EP4 (65), both of which, 
upon activation, cause an increase in adenosine 3′,5′-monophosphate 
(cAMP) levels within the cell. An increase in intracellular cAMP can 
“reprogram” the cell to switch from 5-LO products to the production 
of 15-LO products (28). Our studies show PGE2 signaling through 
EP4 receptors to be important in the resolution of neutrophilic in-
flammation and that this activity is mediated via 15-LO products, 
most likely the anti-inflammatory mediator LXA4.
Human polymorphonuclear leukocytes in vitro markedly in-
crease expression of 15-LO mRNA in the presence of PGE2 (28). 
Our data from whole animals show a significantly increased expres-
sion of the annotated zebrafish 12-LO mRNA following tailfin in-
jury relative to time. Human blood neutrophils exposed to PGE2 
inhibit LTB4 biosynthesis and demonstrate reduced neutrophil 
migration (66). Our data confirm the regulation of neutrophil mi-
gration by PGE2 and LXA4 in an in vivo model of inflammation 
resolution. Neutrophils more readily migrate away from the wound 
site when exposed to exogenous PGE2 or LXA4. The addition of 
PGE2 after the maximum recruitment of neutrophils to the wound 
is able to markedly enhance the reverse migration of neutrophils. 
The mechanism of this step is still unknown, but PGE2 alteration of 
LO activity would fit with its known role in inhibiting neutrophil 
recruitment (67). In our studies, exogenous LXA4 causes neutro-
phils to leave the wound sooner. LXA4 has been shown to inhibit 
chemokine signaling in neutrophils in vitro (68), suggesting a mech-
anism by which LXA4 facilitates neutrophil reverse migration from 
sites of inflammation. Mathematical modeling data from in vivo 
neutrophil migration following zebrafish tailfin wounding suggest 
that neutrophil reverse migration is a phenomenon of stochastic 
redistribution of neutrophils in the tissues (69). This suggests a 
model whereby neutrophils are retained at wounds by a molecular 
“retention signal” and that decay of this signal leads to reverse mi-
gration (12). Chemokine receptor desensitization would be a strong 
candidate for explaining how these retention signals might be ini-
tiated and subsequently decayed. LXA4 interference with these 
signals might be a potential mechanism by which PGE2 ultimate-
ly alters neutrophil migration patterns, leading to inflammation 
resolution.
In this context, an in vivo reporter would be useful to further 
elucidate the presence and activity of PGE2. Understanding the mo-
lecular mechanisms involved in neutrophil removal from wound sites, 
specifically during reverse migration, would greatly improve our un-
derstanding of inflammatory disease and provide potential strategies 
and targets for much needed therapeutic intervention.
MATERIALS AND METHODS
Maintenance and breeding of zebrafish
To visualize both macrophages and neutrophils within the same 
zebrafish larva, triple transgenic fish Tg(cfms:Gal4)i186;Tg(UAS: 
nfsB-mCherry)i149;Tg(mpx:EGFP)i114, as previously described (29), 
were incrossed. Tg(mpx:gal4)sh267;Tg(UASkaede)i222 zebrafish were 
used for photoconversion and neutrophil tracking experiments, sub-
sequently termed mpx:kaede. Tg(mpx:EGFP)i114 zebrafish were used 
to study neutrophils during inflammation. Zebrafish strains were 
maintained according to standard protocols. Adult fish were main-
tained on a 14:10-hour light/dark cycle at 28°C in UK Home Office– 
approved facilities in The Bateson Centre aquaria at the University 
of Sheffield, under AWERB (Animal Welfare and Ethical Review 
Bodies) and UK Home Office–approved protocols.
Inflammation assay
Inflammation was induced in zebrafish embryos by tail transection 
as described previously (70). Embryos were anesthetized at 3 or 8 dpf 
by immersion in tricaine (0.168 mg/ml; Sigma-Aldrich), and tail 
transection was performed using a microscalpel (World Precision 
Instruments). Neutrophils and macrophages were counted at the site 
of transection at various time points including 2, 4, 6, 8, and 24 hpi 
using a fluorescence dissecting stereomicroscope (Leica).
In vivo cell-specific ablation
Metronidazole (Sigma-Aldrich) was dissolved to a concentration of 
2.5 mM in E3 with 0.2% DMSO. Solutions of metronidazole were made 
fresh on the day of use with vigorous agitation until fully dissolved. 
Tg(cfms:Gal4)i186;Tg(UAS:nfsB-mCherry)i149;Tg(mpx:EGFP)i114 
were immersed in metronidazole or E3 and 0.2% DMSO at 2 or 
7 dpf overnight at 28°C for 15 hours. Larvae were wrapped in foil 
during the experiment. At 3 or 8 dpf, larvae were checked for macro-
phage depletion on a fluorescence dissecting stereomicroscope 
(Leica).
Neutrophil and apoptotic cell labeling
Rates of neutrophil apoptosis were assessed by dual staining with 
Rhodamine-TUNEL and FITC-TSA. Transgenic zebrafish larvae 
were injured at 8 dpf and fixed at 24 hpi in 4% paraformaldehyde. 
TUNEL (ApopTag Red; Millipore Corp.) staining labeled apoptotic 
cells with red fluorescence, and TSA (TSAplus kit; Fluorescence 
Systems, PerkinElmer Life and Analytical Sciences) staining labeled 
neutrophils with fluorescein green fluorescence. Neutrophils at the 
wound were imaged on an Eclipse TE2000-U inverted compound 
fluorescence microscope (Nikon), and neutrophil-specific apoptosis 
was assessed by the percentage of TSA-positive neutrophils labeled 
with TUNEL. Red TUNEL–positive–only cells were assessed for to-
tal apoptosis rates.
Cell tracking
To assess neutrophil migration behavior before and after interac-
tion with a macrophage, transgenic larvae Tg(mpx:EGFP)i114 were 
crossed to Tg(mpeg1:mCherry-CAAX)sh378. Three days post fer-
tilization larvae were injured, and images were taken every 3 min 
between 0 and 12 hpi using an Eclipse TE2000-U inverted com-
pound fluorescence microscope (Nikon). Direct contact was de-
fined as when cell membranes could be seen to touch. Comparisons 
of migration behavior were made over a 30-min period before and 
after interaction.
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Compound treatment of zebrafish larvae
Following tail transection at 3 dpf, zebrafish larvae were screened at 
4 hpi for neutrophil recruitment. Selected larvae were immersed in 
1 M PGE2 (Sigma-Aldrich) at 8 hpi with counts performed at 12 hpi 
to look for accelerated inflammation resolution and 24 hpi for cor-
rection of phenotype assays. Concentrations of PGE2 ranged from 
0.01 to 10 M for dose-response assays. The EP4 antagonist AH23848 
(Cayman Chemicals) was used at a final concentration of 1 M. Fish 
were incubated at 2 dpf, and tail transection was performed at 3 dpf. 
PD146176, a 15-LO inhibitor (Sigma-Aldrich), was injected at 6 hpi 
into the Duct of Cuvier to a final concentration of 27 nM in 2 dpf 
larvae. LXA4 (Cayman Chemicals) was injected into the Duct of Cuvier 
to a final concentration of 27 nM at 2 dpf, followed by tail transection 
and 6 hpi counts.
Reverse migration assay
Tail transection of Tg(mpx:gal4)sh267;Tg(UAS:kaede)i222 larvae 
was performed at 3 dpf. Embryos were raised to 8 hpi, incubated in 
1 M PGE2 for 1 hour, and mounted in 0.8% low-melting-point 
agarose (Sigma-Aldrich). An UltraVIEW PhotoKinesis device on an 
UltraVIEW VoX spinning disk confocal microscope (PerkinElmer 
Life and Analytical Sciences) was used to photoconvert Kaede-labeled 
cells at the wound site using 120 pulses of the 405-nm laser at 40% 
laser power. Embryos were transferred to an Eclipse TE2000-U inverted 
compound fluorescence microscope (Nikon), where a 1394 ORCA- 
ERA camera (Hamamatsu Photonics Inc) was used to capture a time-
lapse series with 2.5-min intervals for 2 hours. Tracking analysis of 
red- fluorescing neutrophils was performed in Volocity 6 (Improvi-
sion; PerkinElmer Life and Analytical Sciences), using the intensity of 
fluorescence to identify individually labeled neutrophils over time. 
LXA4 was injected at 4 hpi at a final concentration of 27 nM, neutro-
phils at the wound site was photoconverted at 5 hpi, and larvae were 
time-lapsed between 6 and 15 hpi. Speed data were calculated using 
tracking time lapses, where larvae were incubated in 10 M LXA4. We 
refer to the track a neutrophil takes as the meandering index of the 
neutrophil, where a direct movement in a straight line from A to B is 
given the value of 1. Tracks that are not a straight line fall between 
zero and 1.
Morpholino studies
All morpholinos were obtained from GeneTools LLC. ptges splice 
blocking morpholino is described by Feng et al. (26). Standard control 
morpholino (CoMo; 0.5 nl of 0.4mM) or ptges morpholino was in-
jected into embryos at the one-cell stage previously described (26). 
Injected larvae were incubated in 5 M PGE2 at the onset of epiboly 
to compensate for the PGE2 required for normal development up to 
42 hours post fertilization (hpf ). PGE2 was then withdrawn from the 
larvae at 48 hpf. At 3 dpf, larvae were injured, and neutrophil counts were 
performed at 4, 8, and 24 hpi. Knockdown was assessed in the same 
fish at 48 hpf and 4 dpf using reverse transcription PCR, and primer 
sequences were PTGESF1 5′-CTCGGGAGCGACATACAGTT-3′ 
and PTGESR1 5′-AGCAGATATGCAACGCTGTG-3′. ptges splice 
blocking morpholino leads to deletion of exon 2 and a loss of 83 bp.
Quantitative PCR
Three days post fertilization larvae were injured, and total RNA was 
extracted using TRIzol at various time points after injury. Comple-
mentary DNA synthesis was performed using SuperScript II (Thermo 
Fisher Scientific), and qPCR experiments using a DyNAmo Flash 
SYBR green qPCR kit (Thermo Fisher Scientific) were carried out. 
CT was calculated using elongation factor 1 alpha as a reference 
gene. Relative expression levels were plotted after determining Ct 
by normalizing to a single sample with a high CT value. Primer se-
quences for alox12 gene were alox12F ccacggaatatcaccagatgga and 
alox12R attcagagtcgttgtgggtatc.
gRNA design and CRISPR/Cas9 injection
The online web tool CHOPCHOP was used to design a specific gRNA 
spanning the ATG of ptges. Purified gRNA, Cas9 protein, and tracrRNA 
were purchased from Sigma-Aldrich. The ptges guide sequence is 
gauagaggcucaagaugcucguuuuagagcuaugcuguuuug, targeting sequence 
gatagaggctcaagatgctcggg of the gene. Each embryo was injected with 
1 nl of 6.6 nM gRNA, tracrRNA, and Cas9 protein at the one-cell 
stage. Genomic DNA was extracted from injected larvae, and PCR 
amplification was performed, generating a 345-bp product spanning 
the ATG of the ptges gene (ENSDARG00000020136). Primers used 
were ptges guide F1 gccaagtataatgaggaatggg and ptges guide R1 
aatgtttggattaaacgcgact. Genotype was determined by digestion with 
MwoI. Wild-type PCR products produce 184-, 109-, and 52-bp bands. 
Mutant forms produce 293- and 52-bp bands.
Statistical analysis
Data were analyzed (Prism 7.0; GraphPad Software) using unpaired, 
two-tailed t tests for comparisons between two groups and one-way 
ANOVA (with appropriate posttest adjustment) for other data. A 2 
Fisher’s exact test was used to assess statistical significance in Fig. 2. 
Linear regression analysis was performed on qPCR data in Fig. 6.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/9/eaar8320/DC1
Fig. S1. Reverse transcription PCR demonstrates successful exon deletion.
Fig. S2. PGE2 drives resolution of inflammation in the absence of macrophages by 12 hpi and 
does not alter neutrophil apoptosis.
Fig. S3. Amino acid positions 353 and 418 determine LOX functionality.
Fig. S4. Genotyping method for ptges crispant.
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